Before
The client's situation
- The client needed an API and phytosterol market entry feasibility view.
- The study covered global and Indian demand-supply, trends, buyer behaviour and market gaps.
- Specific APIs, intermediates and key starting materials (KSMs) were shortlisted.
Challenge
The question that had to be answered
Can domestic manufacturing reduce dependency on foreign pharmaceutical suppliers?
MARC's approach
What we did
- 1
Global and Indian market dynamics, growth trends and demand drivers were studied.
- 2
Products were ranked by end-use, competition and regulatory feasibility.
- 3
The India-versus-China manufacturing cost structure and regulatory ecosystem were assessed.
Result
What the work delivered
- High-potential products were ranked to support the decision.
- Manufacturing cost and capacity considerations were translated into feasibility inputs.
- The regulatory pathway was clarified for domestic and international certifications.
Consulting takeaway
For pharma entry, market demand is only one leg. Regulatory feasibility and manufacturing economics decide whether the opportunity is bankable.
API market entryPharma feasibilityIndia vs China costRegulatory pathway
Free Self-Assessment
India Market Entry & Feasibility Scorecard
Before you commission a study like this, see where you stand with a free instant readiness score.